Home
Search
Study Topics
Glossary
|
|
|
|
|
Sponsors and Collaborators: |
Collinge and Associates National Cancer Institute (NCI) |
---|---|
Information provided by: | National Cancer Institute (NCI) |
ClinicalTrials.gov Identifier: | NCT00632398 |
RATIONALE: A multimedia program that teaches massage therapy to cancer patients and their care partners may be effective in lowering stress, reducing symptoms, and improving quality of life. It is not yet known whether massage therapy is more effective than standard care for cancer patients and their care partners.
PURPOSE: This randomized phase II trial is studying how well a multimedia program about massage therapy works for cancer patients and their care partners.
Condition | Intervention | Phase |
---|---|---|
Cancer-Related Problem/Condition Chronic Myeloproliferative Disorders Leukemia Lymphoma Lymphoproliferative Disorder Multiple Myeloma and Plasma Cell Neoplasm Myelodysplastic Syndromes Myelodysplastic/Myeloproliferative Diseases Precancerous/Nonmalignant Condition Unspecified Adult Solid Tumor, Protocol Specific |
Other: educational intervention Other: questionnaire administration Procedure: acupressure therapy Procedure: massage therapy Procedure: psychosocial assessment and care Procedure: stress management therapy Procedure: therapeutic touch |
Phase II |
Study Type: | Interventional |
Study Design: | Randomized, Active Control |
Official Title: | Couples and Cancer: Building Partner Efficacy in Caring |
Estimated Enrollment: | 240 |
Study Start Date: | March 2008 |
Estimated Primary Completion Date: | August 2009 (Final data collection date for primary outcome measure) |
Ages Eligible for Study: | 21 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
DISEASE CHARACTERISTICS:
Cancer patient and their care partner with any of the following characteristics:
PATIENT CHARACTERISTICS:
PRIOR CONCURRENT THERAPY:
United States, Maine | |
Collinge and Associates | Recruiting |
Kittery Point, Maine, United States, 03905 | |
Contact: William Collinge, PhD, MPH 207-439-8049 | |
United States, Massachusetts | |
Greater Boston Chinese Golden Age Center | Recruiting |
Boston, Massachusetts, United States, 02111 | |
Contact: Ka Lam 617-357-0226 ext. 233 | |
Latin American Health Institute | Recruiting |
Boston, Massachusetts, United States, 02116 | |
Contact: Jorge Soler 617-350-6900 ext. 185 |
Principal Investigator: | William Collinge, PhD, MPH | Collinge and Associates |
Responsible Party: | Collinge and Associates ( William Collinge ) |
Study ID Numbers: | CDR0000587451, COLLINGE-06-200 |
Study First Received: | March 7, 2008 |
Last Updated: | February 6, 2009 |
ClinicalTrials.gov Identifier: | NCT00632398 History of Changes |
Health Authority: | Unspecified |
psychosocial effects/treatment unspecified adult solid tumor, protocol specific accelerated phase chronic myelogenous leukemia acute undifferentiated leukemia adult acute lymphoblastic leukemia in remission adult acute myeloid leukemia in remission adult acute myeloid leukemia with 11q23 (MLL) abnormalities adult acute myeloid leukemia with inv(16)(p13;q22) adult acute myeloid leukemia with t(15;17)(q22;q12) adult acute myeloid leukemia with t(16;16)(p13;q22) adult acute myeloid leukemia with t(8;21)(q22;q22) atypical chronic myeloid leukemia blastic phase chronic myelogenous leukemia chronic myelomonocytic leukemia chronic phase chronic myelogenous leukemia |
mast cell leukemia meningeal chronic myelogenous leukemia progressive hairy cell leukemia, initial treatment prolymphocytic leukemia recurrent adult acute lymphoblastic leukemia recurrent adult acute myeloid leukemia recurrent adult T-cell leukemia/lymphoma refractory chronic lymphocytic leukemia refractory hairy cell leukemia relapsing chronic myelogenous leukemia secondary acute myeloid leukemia stage I adult T-cell leukemia/lymphoma stage I chronic lymphocytic leukemia stage II adult T-cell leukemia/lymphoma stage II chronic lymphocytic leukemia |
Blast Crisis Mantle Cell Lymphoma Preleukemia Leukemia, Prolymphocytic Hemorrhagic Disorders Lymphoma, Large-Cell, Anaplastic Neoplasm Metastasis Thrombocythemia, Hemorrhagic Myelodysplastic Myeloproliferative Disease Precursor Cell Lymphoblastic Leukemia-Lymphoma Hematologic Diseases Leukemia, Myeloid, Chronic, Atypical, BCR-ABL Negative Leukemia, Myelomonocytic, Chronic Blood Coagulation Disorders Leukemia, Myeloid |
Waldenstrom Macroglobulinemia Plasmacytoma Leukemia, Myeloid, Accelerated Phase HIV Infections Chronic Myelogenous Leukemia Lymphoma, Non-Hodgkin Precancerous Conditions Blood Protein Disorders Lymphoma, Follicular Sezary Syndrome Lymphoblastic Lymphoma Lymphoma, B-Cell Leukemia Cutaneous T-cell Lymphoma Lymphoma, T-Cell |
Precancerous Conditions Blood Protein Disorders Paraproteinemias Hemostatic Disorders Leukemia Preleukemia Hemorrhagic Disorders Pathologic Processes Syndrome Lymphoma, Large-Cell, Immunoblastic Cardiovascular Diseases Lymphoma Disease Neoplasms by Histologic Type |
Immunoproliferative Disorders Immune System Diseases Hematologic Diseases Myelodysplastic Syndromes Myeloproliferative Disorders Vascular Diseases Multiple Myeloma Lymphatic Diseases Neoplasms Bone Marrow Diseases Lymphoproliferative Disorders Lymphoma, Non-Hodgkin Myelodysplastic-Myeloproliferative Diseases Neoplasms, Plasma Cell |